Daily pill can double survival time for world’s deadliest cancer, trial shows

31 mai 2026 | Andrew Gregory in Chicago
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest (…)
 Site référencé:  The Guardian (Africa)

The Guardian (Africa) 

What’s missing from ‘embarrassing’ Mandelson files ? – The Latest
2/06/2026
Lego launches Pokémon ‘smart’ bricks equipped for interactive battles
2/06/2026
Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery
2/06/2026
New Danish government vows to resist Greenland pressure and tackle cost of living
2/06/2026
What Blair gets wrong about the economy – it is fired by people, not business | Letters
2/06/2026
Funny and full of sex : why you should read Proust’s In Search of Lost Time | Letters
2/06/2026